During sleep deprivation, neurobehavioral functions requiring sustained levels of attention
and alertness are significantly impaired. Discrepancies between subjective measures of …

Individuals with attention-deficit/hyperactivity disorder (ADHD) suffer from a range of
cognitive and behavioral problems that severely impair their educational and occupational …

Background Methylphenidate and atomoxetine are used for the treatment of attention-
deficit/hyperactivity disorder (ADHD). Our previous studies established the validity of the 6 …

Rationale Attention is compromised in many psychiatric disorders, including attention-
deficit/hyperactivity disorder (ADHD). While dopamine and noradrenaline systems have …

Atomoxetine, a noradrenaline reuptake inhibitor (NRI), which is a non-stimulating medicine
that is used for the treatment of patients with attention deficit hyperactivity disorder (ADHD) …

Rationale Delivering orally bioavailable drugs to rodents is an important component to
investigating that route of administration in novel treatments for humans. However, the …

Previous studies have shown that drugs which block the reuptake of catecholamine
neurotransmitters improve impulse control in diseases such as attention deficit hyperactivity …

Amphetamine (AMP) and atomoxetine (ATX) represent two of the most widely studied drug
treatments used in the investigation of impulsive behaviour. While both drugs have relatively …

Atomoxetine (ATX) is a commonly used non-stimulant treatment for Attention deficit
hyperactivity disorder (ADHD). It primarily acts to increase noradrenalin levels; however, at …

Prenatal alcohol treatment (PA) produces a decrease in dopaminergic neuron activity in the
ventral tegmental area, an alteration that is alleviated with methylphenidate treatment …